Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 3
2017 1
2018 2
2019 2
2020 7
2021 20
2022 21
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Delivery platforms for broadly neutralizing antibodies.
Joshi LR, Gálvez NMS, Ghosh S, Weiner DB, Balazs AB. Joshi LR, et al. Curr Opin HIV AIDS. 2023 Jul 1;18(4):191-208. doi: 10.1097/COH.0000000000000803. Epub 2023 May 15. Curr Opin HIV AIDS. 2023. PMID: 37265268 Free PMC article. Review.
SARS-CoV-2-specific ELISA development.
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G. Roy V, et al. J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. J Immunol Methods. 2020. PMID: 32780998 Free PMC article.
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
Naranbhai V, Garcia-Beltran WF, Chang CC, Berrios Mairena C, Thierauf JC, Kirkpatrick G, Onozato ML, Cheng J, St Denis KJ, Lam EC, Kaseke C, Tano-Menka R, Yang D, Pavlovic M, Yang W, Kui A, Miller TE, Astudillo MG, Cahill JE, Dighe AS, Gregory DJ, Poznansky MC, Gaiha GD, Balazs AB, Iafrate AJ. Naranbhai V, et al. J Infect Dis. 2022 Apr 1;225(7):1141-1150. doi: 10.1093/infdis/jiab593. J Infect Dis. 2022. PMID: 34888672 Free PMC article.
Engineering humoral immunity as prophylaxis or therapy.
Deal CE, Balazs AB. Deal CE, et al. Curr Opin Immunol. 2015 Aug;35:113-22. doi: 10.1016/j.coi.2015.06.014. Epub 2015 Jul 14. Curr Opin Immunol. 2015. PMID: 26183209 Free PMC article. Review.
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.
Naranbhai V, Garcia-Beltran WF, Chang CC, Mairena CB, Thierauf JC, Kirkpatrick G, Onozato ML, Cheng J, St Denis KJ, Lam EC, Kaseke C, Tano-Menka R, Yang D, Pavlovic M, Yang W, Kui A, Miller TE, Astudillo MG, Cahill JE, Dighe AS, Gregory DJ, Poznansky MC, Gaiha GD, Balazs AB, Iafrate AJ. Naranbhai V, et al. medRxiv [Preprint]. 2021 Oct 13:2021.07.18.21260732. doi: 10.1101/2021.07.18.21260732. medRxiv. 2021. Update in: J Infect Dis. 2022 Apr 1;225(7):1141-1150. doi: 10.1093/infdis/jiab593. PMID: 34671780 Free PMC article. Updated. Preprint.
COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. Cell. 2021. PMID: 33412089 Free PMC article.
66 results